Roche Holding AG (OTCQX International Premier:RHHBY)

46.36
Delayed Data
As of Sep 17
 +0.35 / +0.76%
Today’s Change
34.86
Today|||52-Week Range
46.63
+14.02%
Year-to-Date
European advisory group backs Roche's Tecentriq in first-line liver cancer
9:46am / Seeking Alpha - Paid Partner Content
Genentech’s Actemra reduces need for ventilation in COVID-19 patients; fails to achieve secondary endpoints
2:33am / Seeking Alpha - Paid Partner Content
Tracking John Rogers' Ariel Investments Portfolio - Q2 2020 Update
8:57am / Seeking Alpha - Paid Partner Content
IPO Update: Inhibikase Therapeutics Proposes IPO Terms
Sep 17 / Seeking Alpha - Paid Partner Content
European advisory group backs expanded use of AstraZeneca's Lynparza
8:45am / Seeking Alpha - Paid Partner Content
Bristol-Myers' Opdivo+Yevroy Application Gets EMA Validation
Sep 17 / Zacks.com - Paid Partner Content
Roche launches new COVID-19 antibodies test
4:45am / Seeking Alpha - Paid Partner Content
OPKO Health Initiates Mid-Stage Study on Coronavirus Therapy
Sep 16 / Zacks.com - Paid Partner Content
Roche launches new COVID-19 antibody test
4:45am / Seeking Alpha - Paid Partner Content
FDA OKs expanded use of Roche cervical cancer test
Sep 16 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close46.01
Today’s open46.11
Day’s range46.04 - 46.48
Volume564,583
Average volume (3 months)1,305,236
Market cap$251.4B
Data as of 09/17/2020

Growth & Valuation

Earnings growth (last year)+26.29%
Earnings growth (this year)+4.36%
Earnings growth (next 5 years)+5.74%
Revenue growth (last year)+6.48%
P/E ratio--
Price/Sales4.54
Price/Book9.16

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)$0.91
Annual revenue (last year)$61.9B
Annual profit (last year)$13.6B
Net profit margin21.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Chart unavailable